Ascendia’s programs are focused on providing our clients with rapid early-stage development services.  Depending on the needs of the specific program, our services can begin with a pre-formulation assessment, including solution-based trial formulations for in-vitro testing.  If a molecule is more advanced, Ascendia® can provide formulation optimization services designed to provide a commercial dosage presentation.  Finally, our programs can conclude with manufacture of cGMP clinical trial materials for a first-in-man study.  The goal of every program is to advance it as quickly as possible to key decision points.

As a specialty CDMO, Ascendia offers expertise in a wide variety of development programs.  We have acquired the capability to work on early-stage formulations of programs as diverse as peptides, high-potency molecules, nano-particles, animal health products, and parenteral dosage forms.  Ascendia prides itself on working on the unique and challenging programs that contribute to the unique selling proposition of our client’s ideas.

Want to learn more about
Ascendia's expertise?

Get up-to-date information

CALL 732-640-0058

or fill out form below and an Ascendia Pharmaceutical expert will reach out to you within 24 hours.